Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377611 · ClinicalTrials.gov registry record · Phase 4
Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 3,054
- Enrollment target
NCT00377611 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 3,054 participants.
The verdict
NCT00377611, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 3,054 participants
- Enrollment target
Study Summary
A study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with Fluarix™
Interventions
- BIOLOGICAL Fluarix™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,054 participants |
| Start Date | 2006-10-05 |
| Est. Completion | 2007-06-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00377611
The ClinicalTrials.gov registry entry for NCT00377611 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 3,054 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluarix™ is the first listed.
NCT00377611 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00377611 about?
NCT00377611 is a clinical study titled "Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™". A study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with Fluarix™
What is the current status of trial NCT00377611?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 3,054 participants. The study started on 2006-10-05. Estimated completion is 2007-06-20.
What interventions are being tested in trial NCT00377611?
The interventions under investigation include: Fluarix™ (BIOLOGICAL).
Who is sponsoring clinical trial NCT00377611?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.